Drs. Eric Konnick, Yassmine Akkari, and Andy Bredemeyer discuss the recent decisions and actions surrounding FDA governance of laboratory developed tests (LDTs) - the Final Rule, current lawsuits, and what it all means for those of us in cancer genomics.

A discussion of challenges and innovative solutions in clinical genomics workflows. Discover how laboratories leverage variant databases and medical genomics knowledge to automate and accelerate the analysis and reporting of genomic alterations in oncology. We also introduce Velsera's completely reimagined solution to these challenges, CGW Plus, showcasing its variant quality assessment, clinical evidence review, and adaptive learning and memory capabilities.